1.Ganacsiga ballaarinta: Yuyue dib-u-helid caafimaad, 100% haysta
Dhowaan, barnaamijka hubinta ganacsiga ayaa muujinaya in Jiangsu Lerun xiriir lens Co., Ltd. uu ku dhacay isbeddello warshadeed iyo ganacsi, saamilaydii asalka ahaa ee Jiangsu Hongyi Garden Construction Engineering Co., Ltd. iyo Danyang xintongqiu muraayadaha indhaha ee Co., Ltd. ayaa ka baxay, iyo saamiga cusub ee Yuyue medical (002223) waxa uu haystaa 100%.Waxaa mudan in la sheego in horaantii 2019, Yuyue uu ku kharash gareeyay ku dhawaad 80 milyan yuan si uu u helo laba shirkadood oo mashiinada indhaha ah.
2.Maajo 24, bogga rasmiga ah ee Xarunta Soo iibsiga Mashiinnada Dawooyinka ee Zhejiang ayaa sii daayay ogeysiis ku saabsan qiimeynta qaddarka bakhaarka daroogada ee 2021, iyo macluumaadka la xiriira 200 ee alaab ee ugu sarreeya ayaa si rasmi ah loogu dhawaaqay.Top10 waxaa gacanta ku hayay shirkado dawooyin oo caalami ah, iyo clopidogrel bisulfate tablets oo ka socday China Stone Pharmaceutical Group iyo Europe Italy Pharmaceutical Co., Ltd., oo ah shirkad dawooyinka gudaha ah, ayaa qabsatay Top11.
3.Nidaamyo taxane ah, dawooyinka hal-abuurka leh ee gudaha ayaa keenay xilli goosasho degdeg ah, iyo ganacsiyada dawooyinka ayaa sidoo kale u tallaabay xilligii guusha guusha.Marka loo eego xogta micnet, tan iyo 2011, ku dhawaad 90 fasalka 1 ee dawooyinka cusub (oo ay ku jiraan fasalka 1 iyo 1.1, marka laga reebo tallaalada, isla hoos ku xusan) ayaa loo oggolaaday liiska, iyo 15 shirkadood oo dawooyin ah ayaa ansixiyay 2 ama in ka badan.Faa'iidooyinka farmashiyaha weyn ee dhaqameed waa caan, Hengrui-na si adag ayuu ugu jiraa meesha ugu horeysa.Ka dib, madaxa biotech ma rabo in laga gudbo, iyo Baiji Shenzhou, Hehuang farmashiyaha iyo dawooyinka zaiding ayaa ku xidhan kaalinta saddexaad.
4.Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd., oo hoos tagta Guangzhou Pharmaceutical Group, oo ka mid ah 500 ee shirkadood ee ugu sarreeya adduunka, ayaa ku dhawaaqay fiidkii 30-kii May in warshadeeda guud ee dawooyinka Baiyunshan ay ka heshay warqad ka timid US FDA (ie US Food). iyo Maamulka Dawooyinka) 29-kii Maajo ansixinta bys10 kaniini si loogu isticmaalo tijaabooyinka kiliinikada ee daawaynta burooyinka adag ee horumarsan ee leh isku-dhafka RET ama isku-bedelka.Warshada Guud ee Dawooyinka ee Baiyunshan waxay qorshaynaysaa inay fuliso tijaabo caafimaad oo furan, xarun badan oo waji ah oo ah dawada cusub ee calaamadaha kor ku xusan marka shuruudaha la buuxiyo mustaqbalka dhow.
5.Suuqa wakiilada isbarbardhiga ayaa mar kale kor u kacaya.Daawooyinka Kelun ayaa ku guuleystay ku dayashada ugu horeysay iyo daawada Hengrui si ay u aadaan badda.Marka loo eego xogta Intranet-ka, sanadka 2021, iibka wakiillada isbarbardhigga ah ee xarumaha caafimaadka dadweynaha ee Shiinaha ayaa kor u dhaafay 17bilyan yuan, koror sannad-sannadka ah 13.05%;Dawooyinka Hengrui, Dawooyinka Guud ee Korontada iyo Dawooyinka Wabiga Yangtze ayaa ka mid ah saddexda ugu sarreeya;Mugga iibka ee shan alaab ayaa kor u dhaafay 1billion yuan, oo ay hogaaminayso cirbadeynta iodixanol.Waqtigan xaadirka ah, 10 nooc oo wakiilada isbarbardhigga ah (40 tilmaamood) ayaa la qiimeeyay, iodophor-kuna waxa uu buuxiyey shuruudaha ururinta dhexe;12 nooc oo ah wakiilada isbarbardhiga (23 qeexitaan alaabooyin) ayaa suuqa ku jira dib u eegis, iyo Beite pharmaceutical waa kan ugu horreeya ee ku daydo.
6.Bishii Juun 7dii, dawooyinka Huiyu waxa ay ku dhawaaqday in ay kabidda Seacross pharmaceuticals 'prosafel injections' ay ka heshay oggolaanshaha diiwaangelinta gudaha Boqortooyada Midowday, taasoo ka dhigaysa shirkaddii ugu horreysay ee hesha oggolaanshaha daawada guud ee Boqortooyada Midowday.Tan iyo sanadkan, alaabada la isku duro ee Huiyu ayaa laga ansixiyay gudaha iyo dibadda.
7.200 ka mid ah kuwa ugu horreeya ayaa la ansixin doonaa!Alaabta kulul ee shirkadaha waaweyn ayaa la kashifay.
Sannadihii ugu dambeeyay, dawooyinka guud ee ugu horreeya ayaa lagu dhiirigeliyay heer qaran.Iyadoo si firfircoon loo qaybinayo dawooyinka hal-abuurka leh, shirkadaha dawooyinka ee hormuudka ka ah ee leh heerka R & D ee sare waxay sidoo kale dardar galiyeen shaqada "ku dayan".Laga soo bilaabo 2018, waxaa jiray ilaa 200 oo badeecado ah oo la codsaday liisaska ku dayashada iyo dib u eegis ayaa lagu hayaa, mana jirto ogolaansho gudaha ah oo loo helay isla alaabooyinkaas.Waxaa la filayaa in loo ogolaado liiska ka dib 2022, oo leh shanta boqol ee bilyan ee ugu sarreeya kulaylka suuqa.
8.Humanwell waxay muujinaysaa xooggeeda!20 fasalka 1 daroogooyinka cusub iyo 18 dawooyinka cusub ee la hagaajiyay ayaa kulul.
Sanadihii la soo dhaafay, Humanwell farmashiyaha, hogaamiyaha suuxinta iyo suuxinta, ayaa si joogto ah u wanaajiyay oo xoojiyay tartankeeda asaasiga ah iyada oo loo marayo "fiirsashada, hal-abuurka iyo caalamiga ah".Dhawaan, shirkaddu waxay ku dhawaaqday in ay ku bixin doonto in ka badan 1.6 bilyan yuan si ay u iibiso hantida hantida si ay u dhexgalaan khayraadka gudaha iyo ballaarinta awoodeeda.Waxaa ka mid ah, hantida hantida ay iibsatay cilmi-baarista hal-abuurka daroogada iyo xarunta horumarinta waxaa loo isticmaali doonaa sida "biomedical-ganacsiga ballaaran iyo hal-abuurka" saldhigga si loo kordhiyo qaabaynta hal-abuurka.Qaybta hore ee 2022, shirkaddu waxay haysataa laba dawo oo cusub oo fasalka 1 ah oo loo oggolaaday isticmaalka kiliinikada, iyo daawadii ugu horreysay ee la hagaajiyay ayaa suuqa ku soo degdegaysa.Ku dayashada kowaad ee kiniiniyada chlorbazam ee carruurta culus ayaa sidoo kale soo jiidatay dareen badan.Intaa waxaa dheer, saddex alaab oo waaweyn ayaa ku dhow inay la kulmaan dufcaddii toddobaad ee iibsiga Qaranka.
9.Zhengda qorrax leh!58 fasalka 1 daroogo cusub iyo 9 ku dayashada ugu horeysay.
Dhawaan, khadka wax soo saarka ee dawooyinka Zhengda Tianqing ayaa sameeyay horumar cusub: soosaarka tq-b3101 kaabsulka, fasalka cusub ee 1 daroogada ka hortagga burooyinka, ayaa la soo sheegay, kiniinka saddexaad ee sophopovir ee gudaha ayaa la ansixiyay, iyo tqc2938 duritaan, heer cusub 1 dawada ka hortagga neefta, ayaa loo ogolaaday isticmaalka kiliinikada Waqtigan xaadirka ah, Zhengda Tianqing Pharmaceutical Co., Ltd. waxay haysataa 73 daawooyin cusub (58 darajo 1 cusub) oo ku jira marxaladda codsiga bukaan-socodka ama ka sarreeya, kuwaas oo 14 daawooyin cusub ah (5 fasalka 1 cusub). daroogooyinka) waxay ku jiraan marxaladda marxaladda III ama ka sarreeya, liiskana waa la filayaa;Marka la eego dawooyinka guud, 54 nooc ayaa la qiimeeyay (21 waa kuwa ugu horreeya), 8 dawo ayaa lagu soo daray dufcaddii toddobaad ee iibka dhexe, iyo 15 nooc oo cusub oo la diiwaangeliyey oo la shaaciyey, kuwaas oo 9 ka mid ah aan la ansixin. markii ugu horeysay (oo ay ku jiraan nuqulka koowaad ee foomka qiyaasta).
JinDun Medicalwaxay leedahay iskaashi cilmi-baaris cilmiyeed oo muddo-dheer ah iyo ku-tallaalidda tignoolajiyada jaamacadaha Shiinaha.Iyada oo Jiangsu kheyraad caafimaad qani ah, waxay leedahay xiriir ganacsi oo muddo dheer India, Koonfur-bari Asia, South Korea, Japan iyo suuqyada kale.Waxa kale oo ay bixisaa adeegyada suuqa iyo iibka ee geeddi-socodka oo dhan laga bilaabo dhexe ilaa API alaabta dhammaatay.Ka faa'iidayso agabka urursan ee Kiimikada Yangshi ee kimistariga fluorine si aad u bixisoadeegyada gaarka ah ee kiimikadala-hawlgalayaasha.Bixi habka hal-abuurka iyo adeegyada cilmi-baarista wasakhaysan si loo beegsado macaamiisha.
Waqtiga boostada: Nov-09-2022